Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Association of Molecular Pathology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this live activity for a maximum of 26.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Application has been made in accordance with Amedco and the joint provider-ship of the ASC and the Association for Molecular Pathology (AMP). Course number 7010, up to 25.50 CEs.
The objectives of the AMP 2021 MGP Review Course are:
The AMP 2021 MGP Review Course will be designed to meet the participants' education needs in the physician competency area of Medical Knowledge, as defined by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS), and to support participants' lifelong learning towards a goal of promoting patient safety and improving patient care. At the completion of this activity, participants should be able to discuss the research underway and/or current molecular approaches to the diagnosis and prognosis of inherited diseases (including Bayesian calculations, pharmacogenetics), molecular hematopathology (including clonality, translocations, and point mutations), cytogenetics, solid and soft tissue tumors, and molecular genetic testing of infectious diseases (including bacterial, fungal, viral, and parasitic pathogens) as well as DNA identity.
The AMP 2021 MGP Review Course is especially targeted to pathologists, geneticists, technical laboratory directors, molecular pathology laboratory personnel, and trainees who:
* DISCLAIMER: AMP makes no guarantee or assurances that completion of its courses or participation in any educational activity will in any manner ensure a passing score on any certification examination or activity post-test, or achievement of certification status. The AMP Molecular Genetic Pathology review course is an educational program provided by the Association for Molecular Pathology, (AMP) and is not sponsored or endorsed by the American Board of Pathology (ABP) or the American Board of Medical Genetics (ABMG).